These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults. Khan BU J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670 [No Abstract] [Full Text] [Related]
53. Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia. Uchida H; Mamo DC; Kapur S; Labelle A; Shammi C; Mannaert EJ; Mann SW; Remington G J Clin Psychiatry; 2008 Aug; 69(8):1281-6. PubMed ID: 18642974 [TBL] [Abstract][Full Text] [Related]
54. Long-acting injectable risperidone. Ehret MJ; Fuller MA Ann Pharmacother; 2004 Dec; 38(12):2122-7. PubMed ID: 15522979 [TBL] [Abstract][Full Text] [Related]
55. Long-term treatment with neuroleptics in psychiatry. Shepherd M; Watt DC Curr Dev Psychopharmacol; 1977; 4():215-47. PubMed ID: 23248 [No Abstract] [Full Text] [Related]
56. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety. Hawley C; Turner M; Latif MA; Curtis V; Saleem PT; Wilton K Hum Psychopharmacol; 2010 Jan; 25(1):37-46. PubMed ID: 20041474 [TBL] [Abstract][Full Text] [Related]
57. New for old? Risperidone long-acting injection in older patients. Hudson-Jessop P; Hughes B; Brinkley N Australas Psychiatry; 2007 Dec; 15(6):461-4. PubMed ID: 17999255 [TBL] [Abstract][Full Text] [Related]